SEGALL BRYANT & HAMILL, LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1006378 CHICAGO, IL

Position in TGTX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$7,065,119

+$946,095 QoQ

Shares Held

128,597

-30.2% QoQ

Ownership

0.084%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#83

of 426 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEGALL BRYANT & HAMILL, LLC holds $322,746,195 across 29 Biotechnology names. TGTX ranks #16 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PTGX	Protagonist Therapeutics, Inc	214,724	$26,320,867
2	HALO	Halozyme Therapeutics, Inc.	317,924	$24,883,911
3	KRYS	Krystal Biotech, Inc.	65,211	$24,236,972
4	PTCT	Ptc Therapeutics, Inc.	271,735	$22,165,423
5	TECH	BIO-TECHNE Corp	312,035	$22,045,272
6	CYTK	Cytokinetics Inc	257,063	$21,899,196
7	MIRM	Mirum Pharmaceuticals, Inc.	178,980	$20,953,188
8	VRTX	Vertex Pharmaceuticals Inc / Ma	37,072	$18,414,774

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,065,119	128,597	-30.2%	Shares	Sole	2026-08-12
2026-03-31	$6,119,024	184,197	-4.3%	Shares	Sole	2026-05-22
2025-12-31	$5,737,053	192,454	+147.3%	Shares	Sole	2026-02-13
2025-09-30	$2,811,717	77,833	-0.6%	Shares	Sole	2025-11-12
2025-06-30	$2,816,937	78,270	-8.4%	Shares	Sole	2025-08-12
2025-03-31	$3,370,121	85,471	+7.5%	Shares	Sole	2025-05-02
2024-12-31	$2,393,491	79,518	+51.8%	Shares	Sole	2025-02-11
2024-09-30	$1,225,402	52,390	+947.8%	Shares	Sole	2024-11-08
2021-03-31	$241,000	5,000	0.0%	Shares	Sole	2021-05-13
2020-12-31	$260,100	5,000	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.